Chennai Meenakshi Multispeciality Hospital Ltd.
Snapshot View

22.95 -0.45 ▼-1.9%

27 January 2023, 04:01:00 PM
Volume: 277

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.cmmh.in
Market Cap 17.18 Cr.
Enterprise Value(EV) 24.67 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 0.02 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 46.72 Trailing Twelve Months Ending 2022-09
Book Value / Share -0.69 Trailing Twelve Months Ending 2022-09
Price to Book Value -33.30 Calculated using Price: 23.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.75 Cr. 7,468,920 Shares
FaceValue 10
Company Profile
Chennai Meenakshi Multispeciality Hospital Limited (CMMH), formerly known as Devaki Hospital was incorporated on May 13, 1992.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.92%
1 Week
-1.29%
1 Month
-2.34%
3 Month
-4.97%
6 Month
+10.60%
1 Year
-6.71%
2 Year
+75.86%
5 Year
-2.05%
10 Year
+270.16%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%)
Return on Capital Employed (%) 22.68 5.53 28.38 4.43 39.57 17.45 24.20 -1.51 59.93
Return on Assets (%) 2.45 -5.12 3.52 -5.75 7.95 0.25 2.84 -6.47 19.59

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds -5 -5 -5 -6 -4 -4 -4 -5 -1 -1
Non Curr. Liab. 13 12 12 12 12 12 12 12 11 12
Curr. Liab. 11 12 11 12 12 11 11 12 11 11
Minority Int.
Equity & Liab. 19 19 18 18 19 19 19 19 21 22
Non Curr. Assets 16 16 15 14 15 14 14 13 14 14
Curr. Assets 3 3 4 4 5 5 5 6 7 8
Misc. Exp. not W/O
Total Assets 19 19 18 18 19 19 19 19 21 22

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 18 19 21 19 23 22 26 19 31 27
Other Income 0 0 0 0 0 1 1 1 0 0
Total Income 18 19 21 19 24 23 26 20 32 28
Total Expenditure -15 -17 -18 -18 -20 -20 -23 -19 -26 -26
PBIDT 3 2 3 1 4 3 3 1 6 2
Interest -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation 0 0
Exceptional Items -1
PAT 0 -1 1 -1 2 0 1 -1 4 0
Adjusted EPS 1 -1 1 -1 2 0 1 -2 5 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 4 4 2 3 2 2 3 3 4
Cash Fr. Inv. -2 -2 -2 0 0 -2 -1 -1 0 -2
Cash Fr. Finan. -3 -2 -2 -1 -1 -1 -1 -2 -1 -2
Net Change 0 0 0 0 1 -1 0 0 2 0
Cash & Cash Eqvt 0 1 1 1 2 1 1 1 3 3

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 55.78 55.78 55.78 55.78 55.78 55.78 55.78 55.78 55.78
Public 44.22 44.22 44.22 44.22 44.22 44.22 44.22 44.22 44.22
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 05 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Based on the confirmation received from Cameo Corporate Services Limited Registrar and Share Transfer Agent of the Company we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted in our records as the registered owner within the stipulated time limit under captioned regulations and the details are furnished to the stock exchange.
Wed, 28 Dec 2022
Closure of Trading Window
Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 it is hereby informed that the Trading Window for the purpose of transaction in the Companys scripts by the Directors and Designated Employees of the company will remain closed from 30th December 2022 till the completion of 48 hours after declaration of the Unaudited financial results for the Quarter/Nine months ended 31th December 2022 in terms of the Companys Code of Prevention of Insider Trading read with SEBI (Prohibition of Insider Trading) Regulations 2015. Accordingly all the designated employees (including Directors) of the Company have been intimated not to trade in the Companys shares during the aforesaid period of closure of Trading Window. Further date of Board Meeting to consider approve and take on record the Unaudited financial resultsfor the Quarter/Nine months ended 31th December 2022 shall be intimated to the Stock Exchange in due course.
Sat, 03 Dec 2022
Announcement under Regulation 30 (LODR)-Demise
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we regret to inform the sad demise of Mr. A.N. Radhakrishnan Promoter & Non-Executive Director of the Company on 03rd December 2022 due to illness.We request you to please take the above on record.

Technical Scans View Details >>

Wed, 25 Jan 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
High Increase in 2 Years High Increase in 2 Years
Closing Near 50 SMA Closing Near 50 SMA

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,518.84 1,040.75 +0.1%
Divi's Laboratories Ltd. 88,552.35 3,385.55 +1.5%
Cipla Ltd. 83,862.25 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 69,879.98 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 60,777.77 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,497.96 1,537.85 -1.3%
Abbott India Ltd. 45,101.64 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.79 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 29.71 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 32.68 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 22.47 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.39 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 65.87 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.15 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.33 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-09 3.83 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.36 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.15 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.62 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.62 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Chennai Meenakshi Multispeciality Hospital Ltd.

What is Chennai Meena Multi share price?

Can I buy Chennai Meena Multi shares now?

What is the Market Cap of Chennai Meena Multi?

What are the key metrics to analyse Chennai Meena Multi?

What is the 52 Week High and Low of Chennai Meena Multi?

What is the trend of Chennai Meena Multi share price?